MarketsStocksBIOCON
BI

Biocon Ltd

NSE: BIOCONBSE: 532523Pharma
412.45
-1.04%
NSE · 15-min delayed
Prev Close
₹337.20
Day High
₹417.35
Day Low
₹411.15
Mkt Cap
₹69,484 Cr
P / E
153.6
P / B
2.0
ROE
1.1%
52W High
₹440.40
52W Low
₹327.60
Key Metrics
Market Cap
₹69,484 Cr
P / E
153.6
P / B
2.0
ROCE
2.9%
ROE
1.1%
Div Yield
0.2%
Revenue · ₹ Cr
6k
FY20
7k
FY21
8k
FY22
11k
FY23
15k
FY24
15k
FY25
17k
FY26
Net Profit · ₹ Cr
871
FY20
846
FY21
772
FY22
643
FY23
1k
FY24
1k
FY25
369
FY26
EPS · ₹ per share
₹6.3
FY20
₹6.2
FY21
₹5.4
FY22
₹3.9
FY23
₹8.6
FY24
₹8.5
FY25
₹2.8
FY26
P / E Ratio · price ÷ TTM EPS
146511616751014Jun 21Jan 23Oct 24Jun 26
P/E 147.8×Median 61.4×TTM EPS
Q1 2026 snapshot
Sales
₹4.57K Cr
Operating profit
-
OPM
-
Net profit
₹199 Cr
EPS
₹0.79
Scorecard · 7 axes
Quality
Weak
32/100
Valuation
Bad
153.6×
Growth
Weak
+1.5%
Profitability
Bad
2.0%
Performance
Good
+27.7%
Entry Point
Weak
94%
Red Flags
Strong
0 flags
Shareholding Pattern
44.9%Promoter
Promoter44.9%
FII7.5%
DII24.1%
Public23.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue3,821.44,453.94,021.64,388.54,290.34,569.1
Net Profit81.1459.489.2132.8-51.8198.6
NPM %2.1%10.3%2.2%3.0%-1.2%4.3%
AlertPre-trade